SITC 2024 Supporters

SITC 2024 Supporters

SITC gratefully acknowledges the following supporters of the society's 39th Annual Meeting & Pre-Conference Programs.

39th Annual Meeting

Platinum

Bristol Myers Squibb

Incyte Corporation 

Gold

Daiichi Sankyo, Inc.

Silver

AstraZeneca Pharmaceuticals

Sanofi US

Bronze

Gilead Sciences, Inc. (Young Investigator Travel Awards)

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Novartis Pharmaceuticals Corporation

Copper

7 Hills Pharma, LLC (The CheckPoints Party)

Bayer HealthCare Pharmaceuticals Inc. (Young Investigator Travel Awards)

Genentech USA, Inc. (Young Investigator Travel Awards for Underrepresented Groups)

Immatics (The CheckPoints Party)


Primer on Tumor Immunology and Cancer ImmunotherapyTM

Silver

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Bronze

Novartis Pharmaceuticals Corporation

Copper

Genmab US, Inc.

Regeneron Pharmaceuticals Inc.


Immune Engineering Workshop

Gold

Bristol Myers Squibb

Bronze

Kite Pharma, Inc.

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Copper

Pfizer, Inc.

Tumor Infiltrating Lymphocytes (TIL) Program

Silver

Iovance Biotherapeutics

Bronze

KSQ Therapeutics, Inc. (Luncheon)

Obsidian Therapeutics, Inc. (Luncheon)

Copper

Achilles Therapeutics

CTMC+

Beyond Checkpoint Inhibitors: New Immuno-oncology Modalities and Approaches (SITC's Industry Program)

Gold

Bristol Myers Squibb

Kite Pharma, Inc.

Silver

Amgen

Bronze

Greater Houston Partnership (Reception)

Novartis Pharmaceuticals Corporation

Supporters as of October 29, 2024